Complete Remission Following Definitive Involved-Site Radiotherapy for Hodgkin Lymphoma-Associated Vanishing Bile Duct Syndrome: A Case Report
Journal of Medical and Radiation Oncology · 10.11.2026 · 6 (1) · 39-45
DOI: 10.53011/jmro.2026.01.07 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical and Radiation Oncology, online erschienen am 31.10.2026. Verfasst von Marta Camacho Manzanares und 9 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Background
Vanishing bile duct syndrome (VBDS) is a rare cholestatic disorder defined by a progressive loss of intrahepatic bile ducts. Although multifactorial, it may present as a paraneoplastic syndrome of Hodgkin´s lymphoma (HL), often associated with poor prognosis due to progressive hepatic failure. Case presentation: We report the case of a 34-year-old woman presenting with jaundice, pruritus, and hyperbilirubinemia (>20 mg/dL). Liver biopsy demonstrated ductopenia without inflammation or tumor infiltration, confirming the diagnosis of VBDS. Imaging studies and a lymph node biopsy confirmed the stage II bulky classical HL with paraneoplastic VBDS. Despite corticosteroids, ursodeoxycholic acid, and dose-reduced chemotherapy, liver function deteriorated, precluding systemic therapy. Definitive involved-site radiotherapy was delivered at 40 Gy in 20 fractions using Volumetric Modulated Arc Therapy (VMAT). After the treatment, bilirubin levels normalized and complete metabolic remission was achieved.
Conclusion
This represents one of the few reported cases of HL-associated VBDS achieving a complete remission following radiotherapy as one of the main therapeutic modalities alongside chemotherapy, corticosteroids, and other treatment approaches. Local tumor control produced both durable lymphoma remission and full reversal of VBDS, suggesting that definitive radiotherapy may represent a therapeutic option when systemic therapy cannot be safely administered. Key words: Hodgkin’s lymphoma, Vanishing bile duct syndrome, paraneoplastic syndrome, ductopenia, radiotherapy.
Zitieren
APA
Manzanares, M. C., Lizarbe, E. F., Arribas, A. L., Muñoz, B. M., Rullán, J. A. D., Cano, M. A., Sánchez, M. M., Nieto, P. M., Martín, J. A., & García, S. S. (2026). Complete Remission Following Definitive Involved-Site Radiotherapy for Hodgkin Lymphoma-Associated Vanishing Bile Duct Syndrome: A Case Report. Journal of Medical and Radiation Oncology, 6(1), 39-45. https://doi.org/10.53011/jmro.2026.01.07
Vancouver
Manzanares MC, Lizarbe EF, Arribas AL, Muñoz BM, Rullán JAD, Cano MA, et al. Complete Remission Following Definitive Involved-Site Radiotherapy for Hodgkin Lymphoma-Associated Vanishing Bile Duct Syndrome: A Case Report. Journal of Medical and Radiation Oncology. 2026;6(1):39-45. doi:10.53011/jmro.2026.01.07
BibTeX
@article{Manzanares2026,
author = {Manzanares, Marta Camacho and Lizarbe, Eva Fernández and Arribas, Ana Lario and Muñoz, Beatriz Mateos and Rullán, José Antonio Domínguez and Cano, Marina Alarz and Sánchez, Mercedes Martin and Nieto, Patricia Martín and Martín, Julen Azcona and García, Sonsoles Sancho},
title = {Complete Remission Following Definitive Involved-Site Radiotherapy for Hodgkin Lymphoma-Associated Vanishing Bile Duct Syndrome: A Case Report},
journal = {Journal of Medical and Radiation Oncology},
year = {2026},
volume = {6},
number = {1},
pages = {39--45},
doi = {10.53011/jmro.2026.01.07}
}
EUVIMED